
Injecting Yourself With a GLP-1? Here Are the Dos and Don’ts
If you’re new to injectable diabetes and obesity medications like Ozempic (semaglutide) and Zepbound (tirzepatide), it could be the first time you’ve ever…

If you’re new to injectable diabetes and obesity medications like Ozempic (semaglutide) and Zepbound (tirzepatide), it could be the first time you’ve ever…

Glucagon-like peptide-1 (GLP-1) receptor agonists have gained a reputation for being a magic bullet for the treatment of type 2 diabetes and obesity.…

When my friend was diagnosed with an infection and prescribed an antibiotic, she did exactly what you’re supposed to do: She asked her…

Microdosing GLP-1 (glucagon-like peptide-1) agonist weight loss drugs involves taking smaller doses of semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), or orforglipron (Foundayo) than…

Sponsored by Hume. Watching the number on the scale go down can feel encouraging, especially when weight loss is one of your health…

(NewsNation) — Women taking popular weight loss and diabetes drugs like Ozempic, Wegovy, Zepbound and Mounjaro should consider stopping them one to two…

Keri M, a marathoner in her 50s, knew the race would be terrible. This feeling couldn’t be chalked up to inexperience. Keri, who…

Key Takeaways GLP-1 medication use is more common among younger generations (Gen Z) than older generations (baby boomers). Millennials are more likely than…

Key Takeaways Among current and past GLP-1 users, 70 percent of those surveyed were satisfied with their weight loss. But the number dropped…

You may have lived with intense food noise, constantly thinking about how to eat, when to eat and what you ate. It may…

Key Takeaways More than 60 percent of surveyed current and past GLP-1 users with type 2 diabetes reported experiencing some form of stigma…